SIC
EW icon

Salem Investment Counselors’s Edwards Lifesciences EW Stock Holding History

Salem Investment Counselors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$813K Sell
8,984
-275
-3% -$23K 0.02% 258
2026
Q1 		$741K Buy
9,259
+388
+4% +$32K 0.02% 250
2025
Q4 		$756K Hold
8,871
– – 0.02% 242
2025
Q3 		$690K Sell
8,871
-1,535
-15% -$120K 0.02% 253
2025
Q2 		$814K Sell
10,406
-150
-1% -$11.2K 0.03% 229
2025
Q1 		$765K Buy
10,556
+940
+10% +$67.3K 0.03% 225
2024
Q4 		$712K Sell
9,616
-800
-8% -$56K 0.02% 237
2024
Q3 		$687K Buy
10,416
+99
+1% +$7.19K 0.02% 237
2024
Q2 		$953K Hold
10,317
– – 0.03% 202
2024
Q1 		$986K Buy
10,317
+1,875
+22% +$158K 0.03% 202
2023
Q4 		$644K Sell
8,442
-1,235
-13% -$85.9K 0.02% 226
2023
Q3 		$670K Buy
9,677
+3,725
+63% +$299K 0.03% 208
2023
Q2 		$561K Hold
5,952
– – 0.02% 226
2023
Q1 		$492K Sell
5,952
-700
-11% -$55K 0.02% 239
2022
Q4 		$496K Sell
6,652
-1,650
-20% -$127K 0.02% 240
2022
Q3 		$686K Hold
8,302
– – 0.03% 203
2022
Q2 		$789K Sell
8,302
-6,106
-42% -$632K 0.04% 197
2022
Q1 		$1.7M Sell
14,408
-45
-0.3% -$5.05K 0.07% 148
2021
Q4 		$1.87M Buy
14,453
+460
+3% +$53.7K 0.07% 142
2021
Q3 		$1.58M Buy
13,993
+3,210
+30% +$366K 0.09% 149
2021
Q2 		$1.12M Buy
10,783
+300
+3% +$28.3K 0.06% 167
2021
Q1 		$877K Buy
10,483
+4,213
+67% +$356K 0.05% 168
2020
Q4 		$572K Buy
6,270
+400
+7% +$33.2K 0.04% 189
2020
Q3 		$469K Buy
5,870
+305
+5% +$23.8K 0.04% 189
2020
Q2 		$385K Buy
5,565
+1,125
+25% +$80K 0.03% 193
2020
Q1 		$279K Hold
4,440
– – 0.03% 205
2019
Q4 		$345K Buy
4,440
+390
+10% +$30.5K 0.03% 214
2019
Q3 		$297K Hold
4,050
– – 0.03% 217
2019
Q2 		$249K Hold
4,050
– – 0.02% 235
2019
Q1 		$235K Hold
4,050
– – 0.02% 185
2018
Q4 		$207K Hold
4,050
– – 0.03% 180
2018
Q3 		$235K Hold
4,050
– – 0.02% 185
2018
Q2 		$197K Buy
4,050
+390
+11% +$18.2K 0.02% 193
2018
Q1 		$166K Hold
3,660
– – 0.02% 198
2017
Q4 		$138K Sell
3,660
-597
-14% -$21.9K 0.02% 220
2017
Q3 		$156K Hold
4,257
– – 0.02% 209
2017
Q2 		$168K Buy
4,257
+597
+16% +$21.8K 0.02% 210
2017
Q1 		$115K Sell
3,660
-8,280
-69% -$259K 0.01% 284
2016
Q4 		$373K Hold
11,940
– – 0.04% 199
2016
Q3 		$4.8K Buy
+11,940
New +$450K 0.06% 162

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Salem Investment Counselors's EW Position: Q2 2026 in Review

Salem Investment Counselors reduced its Edwards Lifesciences (EW) stake by 3% in Q2 2026, selling an estimated $23K and leaving 8,984 shares worth $813K. The position accounts for 0.02% of the portfolio, ranked #258.

Salem Investment Counselors first reported a position in EW in Q3 2016 and has held it in 40 quarters since. The position peaked at $1.87M in Q4 2021. 419 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Salem Investment Counselors held 8,984 shares of Edwards Lifesciences worth $813K as of Q2 2026.
  • Salem Investment Counselors sold 275 Edwards Lifesciences shares in Q2 2026, an estimated $23K.
  • Edwards Lifesciences made up 0.02% of Salem Investment Counselors's portfolio in Q2 2026, its #258 holding.
  • Salem Investment Counselors first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 40 quarters since.
  • Salem Investment Counselors's Edwards Lifesciences position peaked at $1.87M in Q4 2021.
  • 419 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.